Removing race from GFR estimates: balancing potential benefits and unintended consequences.
Publication
, Journal Article
Lucas, A; Wyatt, CM; Inker, LA
Published in: Kidney Int
July 2021
Duke Scholars
Published In
Kidney Int
DOI
EISSN
1523-1755
Publication Date
July 2021
Volume
100
Issue
1
Start / End Page
11 / 13
Location
United States
Related Subject Headings
- Urology & Nephrology
- Kidney
- Glomerular Filtration Rate
- Creatinine
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lucas, A., Wyatt, C. M., & Inker, L. A. (2021). Removing race from GFR estimates: balancing potential benefits and unintended consequences. Kidney Int, 100(1), 11–13. https://doi.org/10.1016/j.kint.2021.02.017
Lucas, Anika, Christina M. Wyatt, and Lesley A. Inker. “Removing race from GFR estimates: balancing potential benefits and unintended consequences.” Kidney Int 100, no. 1 (July 2021): 11–13. https://doi.org/10.1016/j.kint.2021.02.017.
Lucas A, Wyatt CM, Inker LA. Removing race from GFR estimates: balancing potential benefits and unintended consequences. Kidney Int. 2021 Jul;100(1):11–3.
Lucas, Anika, et al. “Removing race from GFR estimates: balancing potential benefits and unintended consequences.” Kidney Int, vol. 100, no. 1, July 2021, pp. 11–13. Pubmed, doi:10.1016/j.kint.2021.02.017.
Lucas A, Wyatt CM, Inker LA. Removing race from GFR estimates: balancing potential benefits and unintended consequences. Kidney Int. 2021 Jul;100(1):11–13.
Published In
Kidney Int
DOI
EISSN
1523-1755
Publication Date
July 2021
Volume
100
Issue
1
Start / End Page
11 / 13
Location
United States
Related Subject Headings
- Urology & Nephrology
- Kidney
- Glomerular Filtration Rate
- Creatinine
- 3202 Clinical sciences
- 1103 Clinical Sciences